Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Boston Biochem™ Recombinant Human Di-Ub/Ub2 WT Chains (K27-linked), CF

Catalog No. UC61B025
Click to view available options
Quantity:
25 μg
This item is not returnable. View return policy
This item is not returnable. View return policy

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human Di-Ub/Ub2 WT Chains (K27-linked) is derived from E. coli. The Recombinant Human Di-Ub/Ub2 WT Chains (K27-linked) has been validated for the following applications: Bioactivity.

Specifications

Accession Number P0CG47
Formulation 1mg/mL (58μM) in sterile, deionized water
Gene ID (Entrez) 7314
Molecular Weight (g/mol) 17 kDa
Quantity 25 μg
Source E. coli-derived human Di-Ubiquitin protein
Storage Requirements Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after opening.
Regulatory Status RUO
Common Name DiUbiquitin
Product Type Recombinant protein
Specific Reactivity 0.1 to 1μM
Conjugate Unconjugated
Recombinant Recombinant
Purity or Quality Grade >95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain. Ub-AQUA analysis: K27: 95.9% K11: 3.9% All other linkages ≤ 0.05%
Show More Show Less

For Research Use Only.

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.